問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
黃國揚
下載
2024-01-06 - 2026-04-30
Condition/Disease
Test Drug
Participate Sites4Sites
Recruiting4Sites
2022-09-01 - 2024-07-15
Participate Sites6Sites
Recruiting6Sites
2022-11-30 - 2027-10-31
Participate Sites9Sites
Recruiting9Sites
2024-07-01 - 2027-11-28
Participate Sites8Sites
Not yet recruiting1Sites
Recruiting7Sites
2023-10-02 - 2028-01-05
Participate Sites10Sites
Recruiting10Sites
2023-10-16 - 2027-09-09
2020-11-01 - 2022-03-11
Non Small Cell Lung Cancer / Urothelial Cancer / Renal Cell Carcinoma / Hepatocellular Carcinoma / Melanoma
INCB086550
Participate Sites7Sites
Recruiting3Sites
Terminated4Sites
2018-06-01 - 2022-09-30
Small cell lung cancer
ONIVYDE
Participate Sites5Sites
Recruiting5Sites
Division of Hematology & Oncology
2020-02-01 - 2023-03-28
Participate Sites2Sites
Recruiting2Sites
全部
